Tamara L. Lotan

AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

Emmanuel S. Antonarakis, Changxue Lu, Hao Wang et al. · New England Journal of Medicine · 2014 · 2.7K citations · Full text

Medicine, Oncology, Pharmacology +17

Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation

Jonathan I. Epstein, Mahul B. Amin, Himisha Beltran et al. · The American Journal of Surgical Pathology · 2014 · 576 citations · Full text

Medicine, Oncology, Urology +17

Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology

Edward M. Schaeffer, Sandy Srinivas, Nabil Adra et al. · Journal of the National Comprehensive Cancer Network · 2023 · 571 citations · Full text

Medicine, Oncology, Urology +17

Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes

Christopher M. Heaphy, Andrea P. Subhawong, Seung‐Mo Hong et al. · American Journal Of Pathology · 2011 · 520 citations · Full text

Medicine, Cancer Biology, Oncology +16

The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance

Himisha Beltran, Andrew M. Hruszkewycz, Howard I. Scher et al. · Clinical Cancer Research · 2019 · 394 citations · Full text

Medicine, Oncology, Urology +17